A Multicenter Phase I/II Study of the BCNU Implant (Gliadel (®) Wafer) for Japanese Patients with Malignant Gliomas

Carmustine (BCNU) implants (Gliadel(®) Wafer, Eisai Inc., New Jersey, USA) for the treatment of malignant gliomas (MGs) were shown to enhance overall survival in comparison to placebo in controlled clinical trials in the United States and Europe. A prospective, multicenter phase I/II study involving...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Med Chir (Tokyo)
Main Authors: AOKI, Tomokazu, NISHIKAWA, Ryo, SUGIYAMA, Kazuhiko, NONOGUCHI, Naosuke, KAWABATA, Noriyuki, MISHIMA, Kazuhiko, ADACHI, Jun-ichi, KURISU, Kaoru, YAMASAKI, Fumiyuki, TOMINAGA, Teiji, KUMABE, Toshihiro, UEKI, Keisuke, HIGUCHI, Fumi, YAMAMOTO, Tetsuya, ISHIKAWA, Eiichi, TAKESHIMA, Hideo, YAMASHITA, Shinji, ARITA, Kazunori, HIRANO, Hirofumi, YAMADA, Shinobu, MATSUTANI, Masao
Formato: Artigo
Idioma:Inglês
Publicado em: The Japan Neurosurgical Society 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533485/
https://ncbi.nlm.nih.gov/pubmed/24739422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa2013-0112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados